Home' Trinidad and Tobago Guardian : March 14th 2014 Contents Tuesday s ruling does
leave open the possibility
that prosecutors could
bring a new indictment.
Guardian www.guardian.co.tt Friday, March 14, 2014
Applications are invited from suitably qualified persons to fill the position of Corporate
Communications Assistant at the North-Central Regional Health Authority (NCRHA).
Corporate Communications Assistant
The Corporate Communications Assistant will be responsible for providing support services
to the Corporate Communications Department, so that the established corporate
communications objectives and strategies may be achieved.
Provide support to the communication liaison between the Authority and both its
internal and external publics.
Assist the Manager- Corporate Communications with organisational projects.
Liaise with communications agencies and suppliers.
Provide support to the Manager in liaison with the press and the development of
Develop and maintain a database of contact information for all external and internal
agencies and institutions.
Assist in the development and distribution of various communications media, such
as newsletter, flyers, etc.
Coordinate faxes, emails and other communications.
Perform other related duties as required.
Prepare Operational and Informational Reports on assigned Corporate Communications
Minimum Requirements and Experience:
At least five (5) O'level passes, two (2) of which should be in Mathematics and
At least two (2) years experience in a related job function
Appropriate specialized training in Public/Corporate Relations
Computer literate- Proficiency in Microsoft Office, including Power Point and Publisher
Certificates acquired at foreign universities MUST be supported by certified transcripts as
well as evidence that the completed programme is accredited in Trinidad and Tobago.
Applications must be submitted along with Curriculum Vitae by March 21, 2014 to:
Office of the Chief Executive Officer
North-Central Regional Health Authority
Building # 39, Third Floor
Eric Williams Medical Sciences Complex
Unsuitable/late applications will not be acknowledged.
Charges against an
Indian diplomat whose
arrest strained US-India
relations have been
dropped by a US judge.
Judge Shira Scheindlin
ruled Devyani Khobra-
gade had diplomatic
immunity at the time of
her indictment on visa
fraud and underpaying
Khobragade, who has
since left the US, said
through a lawyer she felt
the rule of law had pre-
India demanded an
apology after she was
arrested and strip-
Delhi said it was
"shocked and appalled"
at the manner of her
arrest, and ordered a
series of diplomatic
reprisals against the US,
including the withdrawal
of a US diplomat from
the diplomat s father,
welcomed the ruling by
the US judge.
"This is the happiest
moment of our lives. I
have always maintained
that this entire issue was
a lie. The work done by
our foreign affairs min-
istry is admirable," Mr
Khobragade told BBC
US Attorney Preet
Bharara said Ms Khobra-
gade was afforded cour-
tesies most Americans
would not receive during
an arrest and said the
search, done by a female
agent, was a standard
detained in December on
suspicion of visa fraud
and making false state-
ments, after being
accused of paying her
Indian maid below the
US minimum wage.
She returned to India
in January after she was
indicted on criminal
charges and India
refused to waive her
her father Uttam
greeting on her
arrival at the
US Judge drops
Drugs taken to lower the risk of heart attacks
and strokes may have less side-effects than claimed,
Their review of 83,880 patients, published in the
European Journal of Preventative Cardiology, indicated
an increased risk of type-2 diabetes.
But it suggested reports of increases in nausea,
muscle ache, insomnia and fatigue were actually
It is a controversial area as the NHS in England
is considering offering the drugs to millions more
The cholesterol-lowering drugs are already offered
to about seven million people in the UK who have
a one-in-five chance of heart disease in the next
The NHS is considering offering the drugs to even
healthier people who have only a one-in-ten chance
of heart problems.
A team at the National Heart and Lung Institute
in London analysed data from 29 clinical trials.
They suggested statins did reduce deaths, but con-
tributed to a high rate of type-2 diabetes. One in five
new cases of diabetes in people on statins were a
direct result of taking the drugs.
Their analysis suggested other side-effects appeared
at a similar rate in people taking statins and those
given dummy (placebo) pills.
One of the researchers, Dr Judith Finegold, said:
"We clearly found that many patients in these trials
---whose patients are usually well-motivated volunteers
who didn t know if they were getting a real or placebo
tablet---that many did report side-effects while taking
Links Archive March 13th 2014 March 15th 2014 Navigation Previous Page Next Page